Ischemia Modified Albumin: A New Serum Marker For...
Ischemia Modified Albumin: A New Serum Marker for Myocardial Ischemia (9877-08)
Explore the development of ischemia modified albumin test (the albumin cobalt binding test), its use and limitations. This test is able to measure cardiac muscle ischemia prior to necrosis.
PEP hours: 10
CPS/ART credits: 0
Course Type: Express
Start Date: Upon registration
Completion: Up to 52 weeks
Delivery: PDF via email
Equipment: Computer with Internet is required
- Define the term ischemic heart disease.
- Draw the major anatomic details of the heart.
- Briefly describe the four major types of cardiac syndromes.
- Describe the principle of the albumin cobalt binding test as a means of detection of ischemic modified albumin.
- Give an overview of the status of laboratory cardiac marker tests.
- Discuss the limitations of the albumin cobalt binding test as a method for detection of early cardiac ischemia.
- List the approximate sensitivity, specificity, positive and negative predictive values of the albumin cobalt binding test and its interpretation.
- Discuss the possible clinical use for the albumin cobalt binding test.
Author/Instructor: John Chapman, FCSMLS, FIMLS, CLSp(H)
Version Date: October 2008